Indian Journal of Pharmacology 2000; 32: 94-101 EDUCATIONAL FORUM ANTIDOTES TO CYANIDE POISONING: PRESENT STATUS ANTIDOTES TO CYANIDE POISONING: PRESENT STATUS
Division of Pharmacology and Toxicology, Defence Research and Development Establishment,Jhansi Road, Gwalior, 474 002, India.
Cyanide is ubiquitously present in the environment. It is considered as a potent suicidal, homicidal,genocidal and chemical warfare agent. Cyanide toxicity is mediated through inhibition of cellular respiration,but its other complex toxic manifestations are also well documented. There are a number of antidotesavailable for cyanide poisoning (e.g. sodium nitrite, 4-dimethyl aminophenol, sodium thiosulphate, etc.),however, there is still uncertainty about their safety, efficacy and correct indication for use. This reviewprovides a comprehensive account of toxicology of cyanide and the present status of various antidotesemployed clinically or pursued experimentally. KEY WORDS INTRODUCTION
impairs the cellular respiration leading to a cascadeof events culminating in cell death. There are a
Cyanide is regarded as a notorious poison dating
number of antidotes available for cyanide poisoning.
back to antiquity. Hydrogen cyanide (HCN) was first
However, their safety, efficacy and correct indication
isolated from cherry laurel by Swedish chemist, Karl
for use are frequently being debated9. This article
Wilheim Scheele in 1782 and in 1786 he was feared
provides a comprehensive account of the toxicology
to be the first victim of this rapid poison1,2. Later in
of cyanide and the current status of various antidotes
1795 Fontana investigated its mechanism of action,
employed clinically or being pursued experimentally.
followed by Blakes’s attempts to antagonise its toxiceffects. However, molecular basis for the biochemi-
ROUTES OF EXPOSURE AND LETHAL DOSE
cal mechanism of cyanide antagonism was first dem- onstrated in 1933 only3. The ubiquitous existence of
It is not easy to determine what are the lethal doses
cyanide in the environment is associated with the
of cyanide to man. Human cyanide poisoning is as-
toxic gases produced by pyrolysis of plastic or ni-
sociated with a mortality rate of 95% 1. Taken orally
trile-based polymer fibres, ingestion of extracts of
the fatal dose of HCN to adult is estimated at 50-
plants containing cyanogenic glycosides (e.g., cas-
100 mg, and for potassium cyanide (KCN), about 150-
sava) or inhalation from industrial or occupational
250 mg10. However, victims ingesting as much as 3
causes (e.g., electroplating). Administration of cer-
g of KCN have been saved with immediate therapy9.
tain drugs (e.g., sodium nitroprusside and laetrile)
Inhalation of HCN at a concentration of 270 ppm (ap-
also release cyanide when metabolised in the body.
proximately 0.3 mg HCN per litre) will be immedi-
Cyanide poisoning also results from exposure to
ately fatal. Victims having a blood cyanide level of
aliphatic nitrile compounds (e.g. acetonitrile) or by
2.5-3.0 µg/ml frequently succumb to respiratory ces-
dermal absorption /ingestion of cyanide salts and
sation within 20-30 min of exposure or may survive
aliphatic nitriles. Its notoriety as a suicidal, homicidal
even upto 3 hr 9,10. The morbidity or mortality depends
and genocidal agent is well known2,4-7. Use of HCN
upon the magnitude of poisoning, which varies with
as a potent chemical warfare agent is also well
the dose and form of cyanide and the route of poi-
documented 8. Cyanide is a very rapid poison which
soning 9. R. BHATTACHARYA CLINICAL MANIFESTATIONS
carboxylase and 2-keto-4-hydroxy glutarate aldolase involving formation of a cyanohydrin intermediate6.
The clinical picture of acute cyanide poisoning var-
Therefore, cyanide toxicity may not be attributed
ies in both time and intensity depending upon the
solely to a single biochemical lesion but a complex
magnitude of exposure. Various non-specific signs
phenomenon. The primary site of action of cyanide
and symptoms like headache, dizziness, nausea,
is presumed to be the central nervous system (CNS).
vomiting, confusion, coma and incontinence of fae-
In acute cyanide poisoning a rapid inhibition of cyto-
ces and urine occur10. Physiologically a series of
chrome oxidase results in an energy deficit within
events like dyspnoea, incoordination of movement,
the target tissue13,14. Additionally a number of other
cardiac irregularities, convulsive seizures, coma and
enzymatic processes are inhibited which exacerbate
respiratory failure may occur leading to death 4,5,7,10.
the toxicity14,15. This includes antioxidant defence
Pathologically no particular lesions can delineate
enzymes (catalase, superoxide dismutase and glu-
cyanide toxicity, albeit animal experiments indicate
tathione peroxidase). Cyanide is also potent
that the lesions are principally in the central nervous
stimulator of neurotransmitter release both in the CNS
system, predominantly necrosis in the white mat-
and peripheral nervous system16. All of these events
ter5,6,10. Probably the most wide-spread pathologic
contribute to the acute toxic syndrome17. Subacute
condition attributed to chronic cyanide poisoning is
or chronic cyanide poisoning is characterized by pro-
tropic ataxic neuropathy following cassava consump-
longed energy deficit, loss of ionic homeostasis and
oxidative stress leading to CNS pathology18. MECHANISM OF TOXICITY ANTIDOTES
The toxic effect of cyanide is attributed predominantly
Cyanide produces a rapid onset of toxicity which must
to the production of anoxia following inhibition of cy-
have vigorous and immediate treatment to prevent
tochrome oxidase, a terminal mitochondrial respira-
the toxic syndrome. To obtain better protection, a se-
tory chain enzyme. This enzyme contains two heme
ries of newer antidotes either alone or in adjunction
A and two copper ions. Cyanide has a special affinity
with the conventional treatments have been exam-
for the heme ion and the reaction of cyanide with the
ined3-5,17. Their mechanism of action, efficacy and
multimeric iron enzyme complex is facilitated by first
toxicity have been reviewed as part of a joint IPCS
penetration of cyanide to protein crevices, with initial
(UNEP, ILO, WHO)/CEC project to evaluate antidotes
binding of cyanide to the protein followed by binding
used in the treatment of cyanide poisoning19. A wide
of cyanide to heme ion. Thereby, a cyanide-heme
variety of compounds have been used as cyanide
cytochrome oxidase complex is formed which
antidotes and they have been classified into four
renders the enzyme incapable of utilizing the oxy-
major groups based on their mechanism of action:
gen4-6,10. The resultant oxygen saturation of the blood
(i) scavengers, (ii) detoxification, (iii) physiological and
imparts a cherry red colour, which aids the diagno-
sis in most instances of cyanide poisoning. Inhibition
of cytochrome oxidase results in interruption of elec-tron transport chain and the oxidative phosphoryla-
These are compounds that inactivate cyanide by
tion. Resultant anaerobic metabolism with severely
binding it or by forming methaemoglobin, which in
decreased ATP generation and concomitant increase
in lactic acid production eventually leads to tissue hypoxia and metabolic acidosis12-14. The inhibitory a. Methemoglobin formers: The basic aim of rapid
properties of cyanide may be ascribed to its ability to
detoxification of cyanide is prevention or reversal of
complex with metals. Besides, iron containing cyto-
inhibition of cytochrome oxidase by cyanide. This is
chrome oxidase, there are other metallo-enzymes
usually accomplished by providing a large pool of
containing molybdenum, zinc or copper which are
ferric iron in the form of methemoglobin to complex
equally sensitive to cyanide. Other mechanism for
cyanide. Cyanide preferentially competes with the
cyanide inhibition may be attributed to its affinity to
Fe+++ of methemoglobin as compared to that of cyto-
Schiff base intermediates, e.g. ribulose diphosphate
chrome oxidase, and eventually binds with the former
ANTIDOTES TO CYANIDE POISONING: PRESENT STATUS
to form cyanmethemoglobin3-5,20. Thereby, the activ-
vascular system25. However, there are differences in
ity of inhibited cytochrome oxidase is restored. The
individual susceptibility to DMAP which may result
various methemoglobin formers employed as cya-
in an undesirable levels of methemoglobinemia even
after normal therapeutic doses26. Intramuscular in- jection of DMAP results in local abscess and fever. Amyl nitrite: Inhalation of amyl nitrite as a first aid
Its clinical application remains limited on account of
measure to cyanide poisoning is known for many
its other toxicological implications like nephrotoxic-
years3-5,9,19. However, the efficacy of amyl nitrite as
ity27. Co-administration of a reduced dose of rapid
methemoglobin inducer remained disputed on ac-
methemoglobin inducer like DMAP and a slow in-
count of its inability to generate methemoglobin
ducer like SN were also found to be an effective pre-
greater than 6% 20,21, while about 15% is required to
treatment against acute cyanide poisoning. This regi-
challenge one LD dose of cyanide9. Now the pro-
men by virtue of a protracted optimal level of methe-
tective effect of amyl nitrite is attributed to its
moglobinemia provided sustained prophylaxis in
vasodilatory effect that can reverse the early cya-
nide induced vasoconstriction9,19. Artificial ventilation with amyl nitrite broken into ambu bags has been Other methemoglobin formers: Hydroxylamine
reported as a life saving therapy in cyanide poi-
soned dogs, prior to induction of significant level
inducer29-31 that was endowed with an anticonvulsive
property32. In view of cyanide induced convulsions and the toxicity of DMAP, the efficacy of HA co- Sodium nitrite: Sodium nitrite (SN) is the most preva-
administration with SN was also examined in rats33.
lent drug of choice for cyanide poisoning 3-5,23. When
Although, this regimen minimised the cyanide in-
given intravenously (i.v.) it takes about 12 min to gen-
duced convulsions, it was less effective as compared
erate approximately 40% of methemoglobin 9. Inspite
to SN+DMAP treatment. In addition to prophylaxis,
of this delay in inducing a significant level of methe-
co-administration of SN and DMAP or HA were also
moglobinemia, a reasonable protection offered by SN
effective therapeutically34, but their extrapolation to
can be ascribed to its vasodilatory property19. A se-
humans warranted caution in view of the persistent
rious drawback with SN is that i.v. administration may
toxicity of these regimens35,36.
be accompanied by serious cardiovascular embar-rassment, particularly in children, for whom an ad-
The cardiovascular implications and poor pharma-
justed dose is recommended24. Since SN induced
cokinetics of SN led to evaluation of yet another group
methemoglobinemia impairs oxygen transport, it can-
of methaemoglobin formers viz. aminophenones and
not be recommended for fire victims where in most
derivatives [ρ-aminopropiophenone (PAPP), ρ-
instances HCN exposure is accompanied by carbon
aminooctanoylphenone (PAOP), ρ-nitrosopropio-
monoxide poisoning. Since carbon monoxide also
phenone (PNPP) and ρ-hydroxy aminopropio-
impairs oxygen carrying capacity of blood, adminis-
phenone (PHAPP)]. Out of all these agents PAPP
tration of SN would further aggravate the hypoxic con-
was the most effective as prophylaxis37,38. Another
dition. SN is also not advised for individuals with glu-
alternative treatment of cyanide poisoning, involving
cose-6-phosphate dehydrogenase (G6PD) deficient
stroma free methemoglobin solution (SFMS) was pro-
red cells because of possibility of serious hemolytic
posed by Ten Eyck et al 39.Intravenous administra-
tion of this solution did not impair the oxygen carry-ing capacity of blood as caused by most other
4 - Dimethylaminophenol: The relatively slow rate
methemoglobin formers and directly sequestered
of methemoglobin formation by SN prompted the de-
cyanide to protect a 4 X LD dose of sodium cya-
velopment of rapid methemoglobin formers like
nide in rats. Efficacy and safety of this antidote re-
aminophenols. 4-dimethylaminophenol (DMAP) is the
mains to be determined in larger animals.
treatment of choice for cyanide poisoning in Germany. A dose of 3.25 mg/kg., i.v. of DMAP was reported to
b. Cobalt containing compounds: Cobalt ion which
produce methemoglobin level of 30% within 10 min
forms a stable metal complex with cyanide is an ef-
and 15% methemoglobinemia was attained within
fective therapeutic agent against cyanide poison-
one minute without any immediate effect on cardio-
ing 3-5,40. Various cobalt containing compounds known R. BHATTACHARYA
to antagonise cyanide poisoning are discussed
nide poisoning. It is considered safe as oral form of
α-KG is sold as an over-the counter nutritional sup- plement (Klaire Laboratories, San Marcos, CA)45. Dicobalt edetate (Kelocyanor): This agent (300 mg of dicobalt edetate in glucose solution; i.v.) is the cur- DETOXIFICATION
rent treatment of choice in France and United King-dom. Serious side effects like vomiting, urticaria,
Under this group those agents are listed which
anaphylactoid shock, hypotension and ventricular
enzymatically detoxify cyanide by converting it to a
arrythmias have been reported in patients receiving
relatively non-toxic product which is readily eliminated
from the body. The reaction can be catalyzed by aug-menting the levels of the enzyme endogenously or
Hydroxocobalamin (Vitamin B 12a): This agent is
by supplementing the enzyme exogenously or, by
perhaps the most promising cyanide antidote used
providing more substrate to the enzyme, which in
in human toxicology9. With the exchange of hydroxy
this case are sulfur donors. The major mechanism
group of hydroxocobalamin for cyanide, non toxic
of removing cyanide from the body is its enzymatic
cyanocobalamin (Vitamin B12) is formed. However,
conversion by the mitochondrial enzyme rhodanese
use of this antidote remained limited on account of
(thiosulphate-cyanide sulfur transferase, EC 22.214.171.124)
the large dose required to challenge cyanide poison-
to thiocyanate. Transulfuration of cyanide is also fa-
ing. An injectable solution of hydroxocobalamin (5 g
cilitated by β-mercaptopyruvate-cyanide sulfur trans-
in water) is now available in France and Germany. In
ferase (EC 126.96.36.199)10. The enzymatic conversion of
France a 4g hydroxocobalamin solution in 80 ml of
cyanide to thiocyanate requires a source of sulfane
sodium thiosulphate (STS) has also been developed.
sulfur (a divalent ionised sulfur bound to another
Recorded side effects of hydroxocobalamin includes
sulfur atom) which is usually offered by thiosulfates
anaphylactoid reactions and acne19,40.
or other biological compounds containing sulfane
Other cobalt compounds: Cobaltous chloride,
sulfur, like polythionates, thiosulfonates, persulfides
cobaltous acetate, cobalt histidine and sodium co-
etc.50. It is presumed that the sulfane sulfur binds
balt nitrite are also reported to antagonise cyanide
first to the serum albumin to yield sulfane sulfur al-
poisoning. However, none of them has been used
bumin complex which eventually reacts with cyanide
to form thiocyanate5,50. Exogenously administered thiosulfate usually in the form of STS would supple- c. Cyanohydrin formers: Cyanide is a nucleophile
ment this reaction rapidly. STS alone administered
known to react with various carbonyl moieties like
i.v. may be sufficient in moderate cases of cyanide
ketones and aldehydes to yield cyanohydrin deriva-
poisoning while severe cases of poisoning may ne-
tives3-5. Sodium pyruvate was reported to effectively
cessitate co-administration of other antidotes, pref-
challenge acute cyanide poisoning in mice41. Another
erably SN9. STS is contra-indicated in patients with
α-ketocarboxylic acid like α-ketoglutaric acid (α-KG) renal insufficiency as the thiocyanate formed may
is currently being pursued widely as a cyanide anti-
cause toxicity19. Endogenous augmentation of rho-
dote42-45. Protective effect of α-KG was also observed
danese has not been worked out extensively but ex-
against cyanide induced convulsions in mice46. α-
ogenous supplementation has been reported to
KG either alone or in combination with SN and/or
accelerate the transulfuration of cyanide to thiocy-
STS attenuated toxicity in mice exposed to cyanide
anate51-54. However, stability and sensitivity of the
through different routes47. Prophylactic or therapeu-
tic ability of α-KG was also shown to be augmented by oxygen48. Cyanide induced histotoxic hypoxia was PHYSIOLOGICAL
reversed by α-KG which was found to be more effec- tive than cobalt edetate and sodium pyruvate49. Al-
Oxygen appears to be a physiological antagonist.
though, clinical trials of this agent as cyanide anti-
Oxygen alone at hyperbaric pressure has slight pro-
dote has not yet been conducted in humans, based
tective effect in cyanide poisoning but it dramatically
on the promising results in experimental animals, it
potentiates the protective efficacy of SN and/ or STS5.
is presently envisaged as a potential antidote for cya-
This protective mechanism is not yet clear because
ANTIDOTES TO CYANIDE POISONING: PRESENT STATUS
inhibition of cytochrome oxidase by cyanide does not
ers, antipsychotics, nitric oxide generators, other
deplete the availability of oxygen, only cellular utili-
neuroprotective drugs, antioxidants, plasma expand-
sation of oxygen is impaired. It is presumed that in-
ers, glycolytic substrates, carbonyl compounds
tracellular oxygen tension may be high enough to
etc.5,17,61-64. Many of these drugs have not been used
cause non enzymatic oxidation of reduced cyto-
clinically in humans but their results in experimental
chrome or oxygen may displace cyanide from cyto-
animals or in vitro are quite encouraging.
chrome oxidase by mass action55. During transulfura- GLOBAL ATTITUDE AND THE POPULAR
tion there is accumulation of sulphite (SO3-2) which
inhibits the progress of the reaction. It is proposedthat oxygen accelerates the oxidation of sulphite,
A retrospective examination of various cyanide anti-
thereby enhancing cyanide detoxification56.
dotes reveals that there is no unanimity of opinionregarding the efficacy of a particular treatment regi-
men. This is mainly due to different experimentalconditions, test protocols and species of animals
The compounds classified as biochemical antidotes
employed in evaluating various antidotes. Adoption
have largely unexplained mechanism of action and
of a particular treatment in a country is dictated by
are also regarded as non-specific antidotes. These
various factors including the regulatory bodies and
compounds are usually not very effective per se but
the legislations. There is no global unanimity on this
as adjuncts significantly augment the efficacy of con-
issue, like SN and STS combination is the drug of
ventional antidotes. A few chemicals belonging to this
choice for cyanide poisoning in U.S.A. and many other
class of antidotes are discussed below.
countries, France and U.K. have adopted kelocyanorwhile Germany is still continuing with DMAP and STS
Chlorpromazine: The potent vasodilatory action of
combination. However, SN (10 ml of 3% solution) and
nitrites prompted the examination of vasogenic drugs
STS (50 ml 25% solution) combination is still the most
as cyanide antagonist. Chlorpromazine a neurolep-
prevalent treatment in cyanide poisoning. Artificial
tic phenothiazine, was found to significantly potentiate
ventilation with 100% oxygen via Ambu bag contain-
the efficacy of SN and STS combination in cyanide
ing the contents of two ampoules of amyl nitrite (0.6
toxicity5. Its protective effect was attributed to its α-
ml) is usually practiced as the first aid therapy. The
adrenergic blocking property57. Subsequently, the
use of antidote should be restricted to patients in deep
antidotal activity of chlorpromazine was related to its
coma with respiratory insufficiency. Supportive
ability to sustain cellular calcium homeostasis and
therapy of diazepam i.v.(3 x 10 mg) and 4.2% so-
maintenance of membrane integrity by preventing
dium bicarbonate solution to correct the convulsions
peroxidation of membrane lipids1,58.
and metabolic acidosis respectively have also been
Other agents: Other α-adrenergic blocking agents
used in human poisoning. To revert excessive meth-
like phenoxybenzamine and various autonomic
aemoglobinaemia i.v. administration of 30 ml of 1%
drugs, vasodilators such as papaverine, organic ni-
methylene blue solution is also recommended9.
trates and anti-histaminic compounds have shown some antidotal efficacy in cyanide poisoning5. Cya- CONCLUSION
nide induces respiratory cessation mediated through
There are diverse approaches to antagonise cyanide
inhibitory action of released endorphin. Therefore,
toxicity. However, full expression of antidotal potency
stereo-specific opiate antagonist (-) naloxone hydro-
of a regimen principally lies on clinical presentations
chloride was found to protect against cyanide induced
and the immediate judgement. With the resurgence
lethality in mice59. Role of neuronal calcium in cya-
of interest on cyanide antidotes a more effective pro-
nide induced neurotoxicity and beneficial effects of
phylactic or therapeutic regimen can be anticipated
chlor promazine and calcium channel blocker
in near future. Considering the rapidity of cyanide
(diltiazem) are also well documented1,58,60. The recent
poisoning, objective of further research is not to re-
thrust to develop mechanistic based antidotes against
place the established antidotes completely but to
cyanide poisoning has identified some new classes
augment their efficacy to a significant level or evolve
of lead compounds like calcium antagonists, non-hyp-
new regimens with enhanced efficacy and safety
notic barbiturates, anticonvulsants, adrenergic block-
which is acceptable with global consensus. R. BHATTACHARYA ACKNOWLEDGEMENT
Isom GE, Way JL. Effect of oxygen on cyanide intoxicationVI. Reactivation of cyanide inhibited glucose catabolism.
The author is grateful to Dr. R.V. Swamy, Director
J Pharmacol Exp Ther 1974;189:235-43.
and Dr. R. Vijayaraghavan, Head of the Pharmacol-
Solomonson LP. Cyanide as a metabolic inhibitor. In Cya-
ogy and Toxicology Division, Defence R & D Estab-
nide in biology edited by B. Vennesland, E.E. Conn, C.J.
lishment, Gwalior for their keen interest and critical
Knowles, J. Westley & F. Wissing, San Diego, Academic
suggestions in preparation of this manuscript. REFERENCES
Ardelt BK, Borowitz JL, Isom GE. Brain lipid peroxidationand antioxidant defense mechanisms following acute cya-
Maduh EU. Mechanism of cyanide neurotoxicity, Ph.D the-
nide intoxication. Toxicology 1989;56:147-54.
sis submitted to Purdue University, IN, U.S.A., 1989, 1-199.
Kanthasamy AG, Borowitz JL, Isom GE. Cyanide inducedincrease in plasma catecholamines: relationship to acute
Borowitz JL, Kanthasamy AG, Isom GE. Toxicodynamics
toxicity. Neurotoxicol 1991;12:777-84.
of cyanide. In Chemical warfare agents edited by S.M. Somani, San Diego, Academic Press,1992;pp 209-36.
Isom GE, Borowitz JL. Modification of cyanidetoxicodynamics: Mechanistic based antidote development.
Way JL, Sylvester D, Morgan RL, Isom GE, Burrows GE et
Toxicol Lett 1995;82/83:795-9.
al. Recent perspectives on the toxicodynamic basis of cya- nide antagonism. Fundam Appl Toxicol 1984;4:231-9.
Kanthasamy AG, Borowitz JL, Pavlakovic G, Isom GE. Dopaminergic neurotoxicity of cyanide: Neurochemical,
Way JL. Cyanide antagonism. Fundam Appl Toxicol 1983;
histological and behavioral characterization. Toxicol Appl
Way JL. Cyanide intoxication and its mechanism of an-
Van Heijst ANP, Meredith JJ. Antidotes for cyanide poison-
tagonism. Ann Rev Pharmacol Toxicol 1984;24:451-81.
ing. In Basic science in toxicology edited by G.N. Volanis,J. Sims, F. Sullivan & P. Turner, Brighton, Taylor & Francis,1990; pp 558-66.
Ballantyne B. Toxicology of cyanides. In Clinical and Ex-perimental Toxicology of Cyanides edited by B. Ballantyne& T.C. Marrs, Bristol, Wright Pub., 1987;pp 41-126.
Jandorf BJ, Bodansky O. Therapeutic and prophylactic ef-fect of methemoglobinemia in inhalation poisoning by hy-
Baskin SI, Horowitz AM, Nealley EW. The antidotal action
drogen cyanide and cyanogen chloride. J Indust Toxicol
of sodium nitrite and sodium thiosulphate against cyanide
poisoning. J Clin Pharmacol 1992;32:368-75.
Bastian G, Mercker RH, Zur Frage der Zweckmässigkeit
Marrs TC, Maynard RL, Sidell FR. Cyanides. In Chemical
der inhalation von Amylnitrit in der Behandlung der
warfare agents. Toxicology and treatments edited by T.C.
Cyanidvergiftung. Naunyn Schmiedeberg’s Arch Exp Pathol
Marrs, R.L. Maynard & F.R. Sidell, England, John Wiley,
Vick JA, Froehlich HL. Studies on cyanide poisoning. Arch
Van Heijst ANP, Douze JMC, Van Kesteren RG, Van Bergen
Int Pharmacodyn 1985;273:314-22.
JEAM, Van Dijk A. Therapeutic problems in cyanide poi- soning. Clin Toxicol 1987;25:383-98.
Chen KK, Rose CL. Nitrite and thiosulphate therapy in cya- nide poisoning. JAMA 1952;149:113-9.
Ballantyne B. The forensic diagnosis of acute cynide poi-soning. In Forensic toxicology edited by B. Ballantyne,
Berlin CM. The treatment of cyanide poisoning in chil-
Bristol, Wright Pub., 1974; pp 99-113.
dren. Pediatrics 1970;46:193-6.
Osuntokun BO. A degenerative neuropathy wth blindness
Kiese M, Weger N. Formation of ferrihaemoglobin with
and chronic cyanide intoxication of dietary origin. The evi-
aminophenols in the human for the treatment of cyanide
dence in Nigerians. In Toxicology in the tropics edited by
poisoning. Europ J Pharmacol 1969;7:97-105.
R.L. Smith & E.A. Bababunmi, London, Taylor & Francis,1980; pp 16-79.
Van Dijk A, Van Heijst ANP, Douze JMC. Clinical evalua-tion of the cyanide antagonist 4-DMAP in a lethal cyanide
Isom GE, Liu DHW, Way JL. Effect of sublethal dose of
poisoning case. Vet Hum Toxicol 1987;2:38-9.
cyanide on glucose catabolism. Biochem Pharmacol 1975;24:871-5.
Weger NP. Treatment of cyanide poisoning with
ANTIDOTES TO CYANIDE POISONING: PRESENT STATUS
4-dimethylaminophenol (DMAP): Experimental and clini-
Schwartz C, Morgan RL, Way LM, Way JL. Antagonism of
cal overview. Fundam Appl Toxicol 1983;3:387-96.
cyanide intoxication with sodium pyruvate. Toxicol Appl Pharmacol 1979;50:437-41.
Bhattacharya R, Jeevaratnam K, Raza SK, Dasgupta S. Cyanide antagonism in a rodent model. Arch Toxicol 1991;
Moore SJ, Norris JC, Ho IK, Hume AS. The efficacy of α-
ketoglutaric acid in the antagonism of cyanide intoxica- tion. Toxicol Appl Pharmacol 1986;82:40-4.
Cox WW, Wendel WB. The normal rate of reduction of methemoglobin in dogs. J Biol Chem 1942;143:331-40.
Norris JC, Utley WA, Hume AS. Mechanism of antagonis-ing cyanide induced lethality by α-ketoglutaric acid. Toxi-
Kiese M, Munch W. Kinetik der Hämiglobinbildung durch
hydroxylamine. Arch Exp Pathol Pharmacol 1950;211:115- 20.
Dalvi RR, Sawant SG, Terse PS. Efficacy of alpha-ketoglu-taric acid as an effective antidote in cyanide poisoning in
Kruszyna R, Kruszyna H, Smith RP. Comparison of hy-
dogs. Vet Res Commun 1990;14:411-4.
droxylamine, 4-dimethylaminophenol and nitrite protec-tion against cyanide poisoning in mice. Arch Toxicol
Dulaney MD, Brumley M, Willis JT, Hume AS. Protection
against cyanide toxicity by oral alpha-ketoglutaric acid. Vet Hum Toxicol 1991;33:571-5.
Wood JD, Peesker SJ. Anticonvulsive action of GABA- elevating agents. J Neurochem 1975;26:277-82.
Yamamoto HA. Protection against cyanide induced con- vulsions with α- ketoglutarate. Toxicology 1990;61:221-8.
Bhattacharya R, Jeevaratnam K, Raza SK, Dasgupta S. Protection against cyanide poisoning by co-administration
Bhattacharya R, Vijayaraghavan R. Cyanide intoxication
of sodium nitrite and hydroxylamine in rats. Human Exp
in mice through different routes and its prophylaxis by α-
ketoglutarate. Biomed Environ Sci 1991;4:452-60.
Bhattacharya R. Therapeutic efficacy of sodium nitrite and
Delhumeau G, Cruz - Mendoza AM, Lojero CG. Protection
4-dimethylaminophenol or hydroxylamine co- administra-
of cytochrome Coxidase against cyanide inhibition by pyru-
tion against cyanide poisoning in rats. Hum Exp Toxicol
vate and α-ketoglutarate. Effect of aeration in vitro. Toxicol
Appl Pharmacol 1994;126:345-51.
Bhattacharya R, Sugendran K. Biochemical changes in-
Hume AS, Moore SJ, Hume AT. Effects of α -ketoglutaric
duced by two prophylactic regimens for cyanide antago-
acid on the distribution of cyanide and acidosis associ-
nism. Biochem Intern 1992;26:627-35.
ated with cyanide intoxication. Toxicologist 1996;3:98.
Bhattacharya R, Pant SC, Deo Kumar, Dube SN. Toxicity
Westley J, Adler H, Westley L, Nishida C. The sulfur
evaluation of two treatment regimens for cyanide poison-
transferases. Fundam Appl Toxicol 1983;3:377-82.
ing. J Appl Toxicol 1995;15:439-41.
Isom GE, Johnson JD. Sulphur donors in cyanide intoxi-
Marrs TC, Bright JE. Kinetics of methaemoglobin produc-
cation. In Clinical and experimental toxicology of cyanides
tion (I). Kinetics of methaemoglobinaemia induced by cya-
edited by B. Ballantyne & T.C. Marrs, Bristol, Wright Pub.,
nide antidotes, ρ -aminopropiophenone, ρ -hydroxyl amino-
propiophenone or ρ -dimethylaminophenol after intrave- nous administration. Human Toxicol 1986;6:139-45.
Bhatt HR, Linnell JL. The role of rhodanese in cyanidedetoxification: its possible use in acute cyanide poisoning
38. Bright, J.E.; A prophylaxis for cyanide poisoning. In Clini-
in man. In clinical and experimental toxicology of cya-
cal and experimental toxicology of cyanides edited by B.
nides edited by B. Ballantyne & T.C. Marrs, Bristol, Wright
Ballantyne & T.C. Marrs, Bristol, Wright Pub., 1987; pp 359-
Cannon EP, Leung P, Hawkins A, Petrikovics I, DeLoach J,
Ten Eyck RP, Schaerdel AD, Ottinger WE. Stroma-free
Way JL. Antagonism of cyanide intoxication with murine
methemoglobin solution: An effective antidote for acute
carrier erythrocytes containing bovine rhodanese and so-
cyanide poisoning. Am J Emer Med 1985;3:519-23.
dium thiosulphate. J Toxicol Environ Health 1994;41:267- 74.
Linnell JL. The role of cobalamins in cyanide detoxifica-tion. In Clinical and experimental toxicology of cyanides
Petrikovics I, Cannon EP, Mc Guinn WD, Pei L, Pu L,
edited by B. Ballantyne & T.C. Marrs, Bristol, Wright Pub.,
Lindner E, Way JL. Cyanide antagonism with carrier eryth-
rocytes and organic thiosulfonates. Fundam Appl Toxicol
Stereospecific effect of naloxone hydrochloride on cyanide intoxication. Toxicol Appl Pharmacol 1986;83:525-30.
Klassen CD. Non mettallic environmental toxicants: airpollutants, solvents and vapour, and pesticides. In
Johnson JD, Meisenheimer TL, Isom GE. Cyanide induced
Goodman and Gilman’s The Pharmacological Basis of
neurotoxicity: Role of neuronal calcium. Toxicol Appl
Therapeutics., 8th edn. edited by A.G. Gilman, T.W. Rall,
A.S. Nies and P. Taylor, New York, Pergamon Press Inc.,1990; pp 1631.
Bhattacharya R, Lakshmana Rao PV, Parida MM, JanaAM. Antidotal efficacy of antioxidants against cyanide
Litovitz T. The use of oxygen in the treatment of acute cya-
poisoning in vitro. Def Sci J 1999;49:55-63.
nide poisoning. In clinical and experimental toxicology ofcyanides edited by B. Ballantyne & T.C. Marrs, Bristol,
Yamamoto HA, Tang HW. Preventive effect of melatonin
against cyanide-induced seizures and lipid peroxidationin mice. Neorosci Lett 1996;207:89-92.
Kong A, Shen A, Burrows G, Sylvester D, Isom GE, WayJL. Effect of chlorpromazine on cyanide intoxication. Toxicol
Nikhand H, Khan S, Sood C, O’ Brien P. Prevention of cya-
Appl Pharmacol 1983;71:407-13.
nide-induced cytotoxicity by nutrients in isolated rat hepatocytes. Toxicol Appl Pharmacol 1994;128:271-9.
Maduh EU, Johnson JD, Ardelt BK, Borowitz JL, Isom GE. Cyanide induced neurotoxicity: Mechanism of attenuation
Keniston RC, Cabellon S, Yarbrough KS. Pyridoxal 5'-phos-
by chlorpromazine. Toxicol Appl Pharmacol 1988;96:60-7.
phate as an antidote for cyanide, spermine, gentamycinand dopamine toxicity: In in vivo rat studies. Toxicol Appl
Leung P, Sylvester DM, Chiou F, Way LL, Way EL, Way JL.
Professor P.C. Dandiya. EmeritusProfessor and Advisor. RobertHeilig Library. S.M.S. Medical Col-lege, Jaipur, talks of his days inJaipur. He recalls life in Jaipur in hisearly childhood when the Maharajafound a third wife. He also narrateshis stay in Lucknow. Varanasi,Toront, Libya and New Delhi anddwells on his impressions on thefreedom movement, the SecondWorld War and the Muslim Connec-tion.
He traces the introduction of newdrugs from 1943 and writes abouthis experience with LSD, the drugwhich was largely misused in theSixties and Seventies. Vallabh Prakashan SU-221, Pitampura, Delhi-110 034. Price: Rs. 350/-
Deer Oaks Business Park 7272 Wurzbach Unit 801 San Antonio, Tx. 78240 Office 210 270 8595 Fax 210 270 8988 DOT/CO2 LASER RESURFACING CO2 Laser Resurfacing is a procedure used to rejuvenate and correct aging or damaged skin. Dot is commonly used to minimize the appearance of fine lines, effective in treating acne scars and areas of uneven pigmentation. Laser resurfacing is a rewarding experi
Forman, David Abstract Epidemiology of gastric carcinoma. Abstract for presentation at Porto meeting – 27th April 2006-04-03 David Forman Professor of Cancer Epidemiology University of Leeds, Leeds, UK Worldwide, there are currently over 900000 new diagnoses of gastric cancer each year making this the 3rd and 5th most common form of cancer in males and females respective